The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wysenski Nancy since 2011.
This trader's CIK number is 1294596.
At the time of last reporting, Wysenski Nancy was the Director of Alkermes Plc.. (stock ticker symbol ALKS).
Also see all insider trading activities at Alkermes Plc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2012 | VRTX | 0 | $0 | 371,746 | $22,248,471 | 360,704 | $13,868,879 |
2011 | VRTX | 0 | $0 | 5,606 | $162,540 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | ALKS | 0 | $0 | 41,250 | $1,288,773 | 47,207 | $1,284,112 |
2022 | ALKS | 0 | $0 | 0 | $0 | 7,585 | $0 |
2021 | ALKS | 0 | $0 | 0 | $0 | 11,682 | $0 |
2020 | ALKS | 6,940 | $136,371 | 0 | $0 | 0 | $0 |
2019 | ALKS | 4,302 | $142,339 | 0 | $0 | 0 | $0 |
1. Vertex Pharmaceuticals Inc / Ma (VRTX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2012-05-14 | VRTX | Option Ex | 180,000 | 39.02 | 7,022,700 |
2012-05-14 | VRTX | Sale | 180,000 | 64.64 | 11,634,300 |
2012-05-07 | VRTX | Sale | 147,695 | 54.50 | 8,049,377 |
2012-05-08 | VRTX | Sale | 38,009 | 61.60 | 2,341,240 |
2012-05-07 | VRTX | Option Ex | 142,695 | 38.01 | 5,423,123 |
2012-05-08 | VRTX | Option Ex | 38,009 | 37.44 | 1,423,056 |
2012-01-19 | VRTX | Sale | 6,042 | 37.00 | 223,554 |
2011-12-12 | VRTX | Sale | 5,000 | 28.90 | 144,500 |
2011-11-15 | VRTX | Sale | 606 | 29.77 | 18,040 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-07-07 | ALKS | Option Ex | 5,957 | .00 | 0 |
2023-05-09 | ALKS | Sale | 41,250 | 31.24 | 1,288,773 |
2023-05-09 | ALKS | Option Ex | 41,250 | 31.13 | 1,284,112 |
2022-06-14 | ALKS | Option Ex | 7,585 | .00 | 0 |
2021-12-02 | ALKS | Option Ex | 5,578 | .00 | 0 |
2021-05-20 | ALKS | Option Ex | 6,104 | .00 | 0 |
2020-02-24 | ALKS | Buy | 6,940 | 19.65 | 136,371 |
2019-03-14 | ALKS | Buy | 445 | 33.06 | 14,711 |
2019-02-21 | ALKS | Buy | 3,857 | 33.09 | 127,628 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wysenski Nancy (Director of Alkermes Plc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.